Proteome Sciences plc (PMSNF)
USD 0.03
(7.14%)
USD 0.03
(7.14%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6.4 Million USD | -31.97% |
| 2022 | 9.4 Million USD | 35.84% |
| 2021 | 6.92 Million USD | 7.54% |
| 2020 | 6.44 Million USD | 4.92% |
| 2019 | 6.13 Million USD | 58.09% |
| 2018 | 3.88 Million GBP | -15.07% |
| 2017 | 4.57 Million GBP | 34.85% |
| 2016 | 3.39 Million GBP | 22.23% |
| 2015 | 2.77 Million GBP | 77.7% |
| 2014 | 1.56 Million GBP | -26.94% |
| 2013 | 2.13 Million GBP | 85.32% |
| 2012 | 1.15 Million GBP | 12.91% |
| 2011 | 1.02 Million GBP | -89.77% |
| 2010 | 9.98 Million GBP | 664.17% |
| 2009 | 1.3 Million GBP | 53.83% |
| 2008 | 849 Thousand GBP | 219.17% |
| 2007 | 266 Thousand GBP | 291.18% |
| 2006 | 68 Thousand GBP | 325.0% |
| 2005 | 16 Thousand GBP | -78.08% |
| 2004 | 73 Thousand GBP | -57.06% |
| 2003 | 170 Thousand GBP | -0.58% |
| 2002 | 171 Thousand GBP | 0.0% |
| 2001 | - GBP | 0.0% |
| 2000 | - GBP | 0.0% |
| 1999 | - GBP | 0.0% |
| 1998 | - GBP | 0.0% |
| 1997 | - GBP | 0.0% |
| 1996 | - GBP | 0.0% |
| 1994 | - GBP | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 2.8 Million USD | 0.0% |
| 2023 Q2 | 4.07 Million USD | 0.0% |
| 2023 FY | 6.4 Million USD | -31.97% |
| 2023 Q4 | 2.31 Million USD | 0.0% |
| 2022 FY | 9.4 Million USD | 35.84% |
| 2022 Q2 | 3.94 Million USD | 0.0% |
| 2022 Q4 | 5.48 Million USD | 0.0% |
| 2021 FY | 6.92 Million USD | 7.54% |
| 2021 Q2 | 2.7 Million USD | 0.0% |
| 2021 Q4 | 4.27 Million USD | 0.0% |
| 2020 Q4 | 3.88 Million USD | 0.0% |
| 2020 FY | 6.44 Million USD | 4.92% |
| 2020 Q2 | 2.31 Million USD | 0.0% |
| 2019 Q4 | 3.85 Million USD | 0.0% |
| 2019 FY | 6.13 Million USD | 58.09% |
| 2019 Q2 | 2.19 Million USD | 0.0% |
| 2018 FY | 3.88 Million GBP | -15.07% |
| 2017 FY | 4.57 Million GBP | 34.85% |
| 2016 FY | 3.39 Million GBP | 22.23% |
| 2015 FY | 2.77 Million GBP | 77.7% |
| 2014 FY | 1.56 Million GBP | -26.94% |
| 2013 FY | 2.13 Million GBP | 85.32% |
| 2012 FY | 1.15 Million GBP | 12.91% |
| 2011 FY | 1.02 Million GBP | -89.77% |
| 2010 FY | 9.98 Million GBP | 664.17% |
| 2009 FY | 1.3 Million GBP | 53.83% |
| 2008 FY | 849 Thousand GBP | 219.17% |
| 2007 FY | 266 Thousand GBP | 291.18% |
| 2006 FY | 68 Thousand GBP | 325.0% |
| 2005 FY | 16 Thousand GBP | -78.08% |
| 2004 FY | 73 Thousand GBP | -57.06% |
| 2003 FY | 170 Thousand GBP | -0.58% |
| 2002 FY | 171 Thousand GBP | 0.0% |
| 2001 FY | - GBP | 0.0% |
| 2000 FY | - GBP | 0.0% |
| 1999 FY | - GBP | 0.0% |
| 1998 FY | - GBP | 0.0% |
| 1997 FY | - GBP | 0.0% |
| 1996 FY | - GBP | 0.0% |
| 1994 FY | - GBP | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -601.056% |
| Arrayit Corporation | 4.37 Million USD | -46.224% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 75.247% |
| Bioqual, Inc. | 58.59 Million USD | 89.076% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 58.155% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.913% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -0.541% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -508.663% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 84.084% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -1330.315% |
| InVitro International | 792.62 Thousand USD | -707.522% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 42.497% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | 11.4% |
| NovelStem International Corp. | 12 Thousand USD | -53238.7% |
| Optigenex Inc. | 465.97 Thousand USD | -1273.617% |
| PharmChem, Inc. | 6.01 Million USD | -6.457% |
| Response Genetics, Inc | 18.04 Million USD | 64.52% |
| Rennova Health, Inc. | 13.03 Million USD | 50.901% |
| RushNet, Inc. | 1.78 Million USD | -258.002% |
| ScreenPro Security Inc. | 1.91 Million USD | -234.394% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -68.657% |
| Todos Medical Ltd. | 7.69 Million USD | 16.821% |